Inventiva S.A (IVA) | Financial Analysis & Statements
Inventiva S.A. | Mid-cap | Healthcare
Inventiva S.A. | Mid-cap | Healthcare
Financial Overview
Latest Annual: 2024Income Metrics
Revenue
9.2M
Operating Income
-94.0M
-1,021.84%
Net Income
-184.2M
-2,002.76%
EPS (Diluted)
-€3.08
Balance Sheet Metrics
Total Assets
119.0M
Total Liabilities
225.6M
Shareholders Equity
-106.6M
Cash Flow Metrics
Operating Cash Flow
-87.4M
Free Cash Flow
-86.3M
Revenue & Profitability Trend
Inventiva S.A Income Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 9.2M | 17.5M | 12.2M | 4.2M | 372.0K |
| Cost of Goods Sold | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
| Operating Expenses | 102.5M | 119.9M | 68.8M | 53.3M | 29.6M |
| Operating Income | -94.0M | -102.7M | -56.9M | -51.2M | -26.5M |
| Pre-tax Income | -183.9M | -109.8M | -54.3M | -49.3M | -33.6M |
| Income Tax | 313.0K | 607.0K | -20.0K | 364.0K | 0 |
| Net Income | -184.2M | -110.4M | -54.3M | -49.6M | -33.6M |
| EPS (Diluted) | -€3.08 | -€2.43 | -€1.31 | -€1.27 | -€0.99 |
Income Statement Trend
Inventiva S.A Balance Sheet From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | 111.5M | 48.2M | 106.4M | 115.6M | 133.0M |
| Non-Current Assets | 7.5M | 21.4M | 9.6M | 6.4M | 5.9M |
| Total Assets | 119.0M | 69.6M | 116.0M | 122.0M | 138.9M |
| Liabilities | |||||
| Current Liabilities | 120.7M | 50.2M | 30.7M | 22.9M | 13.9M |
| Non-Current Liabilities | 104.9M | 51.4M | 39.8M | 10.3M | 13.8M |
| Total Liabilities | 225.6M | 101.6M | 70.5M | 33.1M | 27.7M |
| Equity | |||||
| Total Shareholders Equity | -106.6M | -32.0M | 45.5M | 88.9M | 111.2M |
Balance Sheet Composition
Inventiva S.A Cash Flow Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -184.2M | -110.4M | -54.3M | -49.6M | -33.6M |
| Operating Cash Flow | -87.4M | -109.1M | -52.4M | -58.0M | -43.3M |
| Investing Activities | |||||
| Capital Expenditures | -333.0K | -409.0K | -520.0K | -445.0K | -292.0K |
| Investing Cash Flow | 8.7M | -7.7M | 8.9M | -1.8M | -8.6M |
| Financing Activities | |||||
| Dividends Paid | - | - | - | - | - |
| Financing Cash Flow | 87.4M | 29.1M | 67.5M | 25.4M | 121.7M |
| Free Cash Flow | -86.3M | -82.2M | -45.5M | -48.2M | -30.9M |
Cash Flow Trend
Inventiva S.A Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
-0.88
Forward P/E
-1.95
Price to Book
-0.99
Price to Sales
26.89
PEG Ratio
-1.95
Profitability Ratios
Profit Margin
0.00%
Operating Margin
-384.43%
Return on Equity
172.73%
Return on Assets
-63.60%
Financial Health
Current Ratio
0.92
Debt to Equity
-1.70
Beta
0.62
Per Share Data
EPS (TTM)
-€3.08
Book Value per Share
-€1.12
Revenue per Share
€0.24
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| iva | 379.0M | -0.88 | -0.99 | 172.73% | 0.00% | -1.70 |
| Medincell S.A | 565.5M | -18.81 | - | 61.33% | -66.50% | -1.44 |
| Valneva SE | 409.5M | 70.64 | 2.11 | -44.11% | -43.21% | 120.48 |
| BNP Paribas Easy | 456.7M | 15.91 | - | -96.39% | -27.22% | 2.22 |
| Abivax SA | 331.7M | -1.96 | -52.78 | -196.12% | 0.00% | -16.16 |
| Viridian | 415.4M | 50.43 | 0.40 | 0.93% | 2.05% | 103.04 |
Financial data is updated regularly. All figures are in the company's reporting currency.